CD9 is an adverse prognostic marker and promising therapeutic target in high-risk pediatric B-precursor acute lymphoblastic leukemia
Refereed conference paper presented and published in conference proceedings


全文

其它資訊
著者Chi Zhang, John Tak Kit Cheung, Kathy Yuen Yee Chan, Han Wang, Toni Ki Fong Man, Karen Li, Chi Kong Li, Kam Tong Leung
會議名稱24th Congress of the European Hematology Association
會議開始日13.06.2019
會議完結日16.06.2019
會議地點Amsterdam
會議國家/地區荷蘭
出版年份2019
月份6
語言美式英語

上次更新時間 2019-28-11 於 12:45